The release of the adipocytokine visfatin is regulated by glucose and insulin

[1]  M. Wolzt,et al.  Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. , 2006, The Journal of clinical endocrinology and metabolism.

[2]  M. Fasshauer,et al.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.

[3]  R. Paschke,et al.  Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. , 2005, American journal of physiology. Endocrinology and metabolism.

[4]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[5]  N. Klöting,et al.  Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. , 2005, Biochemical and biophysical research communications.

[6]  R. Paschke,et al.  Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. , 2005, The Journal of endocrinology.

[7]  M. Lu,et al.  Phosphatidylinositol 3-Kinase-Mediated Effects of Glucose on Vacuolar H+-ATPase Assembly, Translocation, and Acidification of Intracellular Compartments in Renal Epithelial Cells , 2005, Molecular and Cellular Biology.

[8]  M. Christ-Crain,et al.  Somatostatin is expressed and secreted by human adipose tissue upon infection and inflammation. , 2004, The Journal of clinical endocrinology and metabolism.

[9]  Li Chang-hui,et al.  Celecoxib simulates respiratory burst through pertussis toxin-sensitive G-protein, a possible signal for beta 2-integrin expression on human neutrophils. , 2004, European journal of pharmacology.

[10]  S. Myou,et al.  Activation of Group IV Cytosolic Phospholipase A2 in Human Eosinophils by Phosphoinositide 3-Kinase Through a Mitogen-Activated Protein Kinase-Independent Pathway 1 , 2003, The Journal of Immunology.

[11]  J. Chiasson,et al.  Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation. , 2003, American journal of physiology. Endocrinology and metabolism.

[12]  P. Jansson,et al.  Increased lactate release per fat cell in normoglycemic first-degree relatives of individuals with type 2 diabetes. , 2001, Diabetes.

[13]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[14]  R. Somwar,et al.  Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes , 2000, Diabetologia.

[15]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[16]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[17]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[18]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[19]  K. Siddle,et al.  Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor. , 1987, The Biochemical journal.

[20]  R. Juhl,et al.  Effect of whole blood on insulin adsorption onto intravenous infusion systems. , 1980, American journal of hospital pharmacy.

[21]  Shyi-Jang Shin,et al.  Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. , 2006, The Journal of clinical endocrinology and metabolism.

[22]  M. Wolzt,et al.  Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. , 2003, Diabetes.